SCHEMBL37679

SCHEMBL37679

Fc1cccc([Mg]Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31693851 1.00
Iodide SCHEMBL1864364 0.98 ACHE (0.41)
SCHEMBL20184788 0.75
SCHEMBL4169934 0.75
Hydrochloric Acid SCHEMBL8042334 0.73 ACHE (0.41)
SCHEMBL28311260 0.73 NFE2L2 (0.45)
Bromide SCHEMBL1022118 0.73 ACHE (0.41)
SCHEMBL307607 0.73 CA12 (0.45)
SCHEMBL3458234 0.72 PTPN5 (0.40)
SCHEMBL3458231 0.72 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1027 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 WO claimed
US-9534001-B2 Organomagnesium synthesis agent CHEMETALL GMBH (DE) 2017-01-03 US claimed
EP-1833817-B1 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-10-13 EP claimed
US-7728135-B2 Synthesis of CCR5 receptor antagonists SCHERING CORPORATION (US) 2010-06-01 US claimed
US-20100063280-A1 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS SCHERING CORPORATION 2010-03-11 US claimed
US-20100036125-A1 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS SCHERING CORPORATION 2010-02-11 US claimed
EP-2125733-A1 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS SCHERING CORPORATION (US) 2009-12-02 EP claimed
CN-100548950-C Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2009-10-14 CN claimed
WO-2008079284-A1 PROCESS FOR PREPARING CCR-5 RECEPTOR ANTAGONISTS UTILIZING 4-SUBSTITUTED 1-CYCLOPROPANE-SULFONYL-PIPERIDINYL COMPOUNDS SCHERING CORPORATION (US) 2008-07-03 WO claimed
CN-101137646-A Synthesis of CCR5 receptor antagonists SCHERING CORP (US) 2008-03-05 CN claimed
EP-1833817-A2 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2007-09-19 EP claimed
EP-1594824-A4 PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF ATHEROGENICS INC (US) 2007-04-04 EP claimed
US-20060258863-A1 Synthesis of CCR5 antagonists SCHERING CORPORATION 2006-11-16 US claimed
WO-2006074270-A2 SYNTHESIS OF CCR5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2006-07-13 WO claimed
CN-1759084-A Process for preparing esters and ethers of probucol and derivatives thereof ATHEROGENICS INC (US) 2006-04-12 CN claimed
EP-1594824-A2 PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF Atherogenics, Inc. (US) 2005-11-16 EP claimed
US-20040204485-A1 Process of preparing esters and ethers of probucol and derivatives thereof CRABTREE ACQUISITION CO, LLC 2004-10-14 US claimed
WO-2004062622-A2 PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF ATHEROGENICS, INC. (US) 2004-07-29 WO claimed
US-6458962-B1 VIRICIDES FOR TREATMENT OF AIDS AND HYDROGENATION OF COMPOUNDS THE UNIVERSITY OF TENNESSEEE RESEARCH CORPORATION 2002-10-01 US claimed
WO-2000056332-A1 SULTAMS: CATALYST SYSTEMS FOR ASYMMETRIC REDUCTION OF A C=N INTERMEDIATE BIOLOGICAL COMPOSITIONS AND METHODS FOR MAKING THE SULTAMS THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 2000-09-28 WO claimed